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oClinical Value of Myocardial
Contrast Delayed Enhancement
With Multidetector Computed
Tomography
We read with great interest the article by Sato et al. (1) that
valuated the prognostic value of myocardial contrast delayed
nhancement with 64-slice multidetector computed tomography
MDCT) after acute myocardial infarction. They should be
ommended for conducting the study elegantly. However, a few
nteresting points arise from the analysis that we believe may be
ertinent and should be answered.
Because MDCT can detect peri-infarct tissue heterogeneity
hat can trigger ventricular arrhythmias (2), which are a common
ause of morbidity and mortality in patients who have had a
yocardial infarction. Did the authors make an attempt to evaluate
nd correlate peri-infarct heterogeneity with prognosis? Also,
utomated implantable cardioverter-defibrillators (AICDs) are
nown to improve the prognosis in a subset of patients who have
ad a myocardial infarction (3), so it would be interesting to know
he AICD distribution among various tertiles and among event
roups and whether the authors adjusted its distribution as a
ossible confounding factor.
Were patients with high levels of biomarkers that are known to
e associated with poor prognosis and are highly correlated with
elayed enhancement size (creatine kinase-myocardial band, tro-
onin, poor left ventricular ejection fraction) treated more aggres-
ively, or was any attempt made to standardize the therapy after
ospital discharge?
Because the number of segments with transmural infarct (on the
7-segment model) is a strong and independent predictor of
rognosis (4), it would be interesting to know if authors made an
ttempt to determine which is the better prognostic indicator: the
umber of segments involved or infarct size (e.g., multiple seg-
ents with subendocardial infarct versus few segments with transmu-
al infarct).
Did the authors make any attempt to study the significance of
alcium deposits in acute infarct detected on MDCT and its
mpact on prognosis?
MDCT is an excellent alternative in situations where magnetic
esonance imaging (MRI) is contraindicated and attributing to its
mproving resolution and reduced partial volume effect that results
n a more accurate assessment of area amenable to revasculariza-
ion, which might replace MRI in the future. However, the
bsence of a universally acceptable protocol for delayed imaging is
critical road block due to the time dependent nature of the
ontrast uptake. Another limitation is hyperenhancement of both
cute and chronic infarct, which limit the role of delayed enhance-
ent on multidetector computed tomography in patients with a
istory of myocardial infarction. d*Abhishek Sharma, MD
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We thank Drs. Sharma and Chatterjee for their comments in regards
to our recently published paper (1). A previous report demonstrated
hat multidetector computed tomography could detect peri-infarct
issue heterogeneity 6 months after myocardial infarction (MI) that
ould trigger ventricular arrhythmias (2). However, we could not
etect peri-infarct tissue heterogeneity and calcium deposits of infarcts
mmediately after primary percutaneous coronary intervention. Acute
I is associated with myocardial edema during the acute phase (3),
nd therefore, this also may influence the extent of myocardial
ontrast delayed enhancement. We agree that automatic implantable
ardioverter-defibrillators (AICDs) are known to improve the prog-
osis in a subset of patients who have had an MI, but only a few
atients received AICD therapy in our study. There is a low incidence
f sudden cardiac death in survivors of MI in Japan. During an
verage follow-up of 4.1 years, 1.2% of 4,122 consecutive patients
ith acute MI discharged from the hospital had sudden cardiac death
4). AICDs are implanted only in high-risk patients with cardiac
ysfunction (left ventricular ejection fraction 40%), nonsustained
entricular tachycardia, and sustained ventricular tachycardia induced
uring an electrophysiological study.
The purpose of our study was to evaluate the clinical value of
yocardial contrast delayed enhancement with multidetector computed
omography for predicting clinical outcome after acute MI. Therefore,
ur patients were treated with standard therapy after hospital discharge.
The number of left ventricular segments with transmuralelayed enhancement has been shown to be a major factor for the
R
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August 7, 2012:563–5prediction of prognosis (5). According to univariate analysis in our
study, the number of left ventricular segments showing transmural
extent was associated significantly with cardiac events. After
adjustment for multiple confounders, this parameter lost its pre-
dictive power, and myocardial contrast delayed enhancement size
was found to be the only significantly independent predictor of
cardiac events. The definition of hyperenhancement has not been
standardized; thus, there was a limitation because of the use of a
global classification, in particular for patients with both transmural
and subendocardial hyperenhancement. Specific optimal cutoff
values for normal and infarct cores are unknown and are likely
dependent on study quality. Further large studies to confirm these
findings in clinical examinations will be needed.
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The Predictive Value of Plasma
Neutrophil Gelatinase-Associated
Lipocalin on Cardiovascular
Death and All-Cause Mortality
Might Be Mediated by Leukocytosis
We read with interest the paper by Daniels et al. (1), who
concluded that higher levels of plasma neutrophil gelatinase-
associated lipocalin (NGAL) are associated independently with an
increased risk of cardiovascular death and all-cause mortality in a
cohort of older community-dwelling adults. The lack of correlationwith renal function led the authors to conclude that plasma NGAL
provides prognostic information that is independent of glomerular
filtration rate, and the modest correlation with C reactive protein
also underlines that NGAL would reflect a pathophysiological
process distinct from inflammation. We (2), as well as others (3),
have shown independently that serum, but not urinary, NGAL
levels are influenced dramatically by leukocytosis, especially by a
high neutrophil count. The paper by Daniels et al. (1) lacks data
regarding leukocyte or neutrophil counts, and therefore, it cannot
be excluded that the significant role of plasma NGAL in predict-
ing mortality and cardiovascular outcomes observed in this study
might have been mediated largely by these untested parameters,
because leukocytosis is per se a significant predictor of noninfective
mortality and morbidity, particularly resulting from cardiovascular
or cerebrovascular causes (4), thereby biasing their results.
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We thank Drs. Lippi and Cervellin for their interest in our study
(1). Although leukocyte count was not measured at the 1992
through 1996 Rancho Bernardo study visit, 802 (58%) of the 1,393
individuals in our study did undergo leukocyte count measurement
in a previous visit approximately 4 years earlier. In these individ-
uals, the correlation between potentially log (neutrophil gelatinase-
associated lipocalin) and leukocyte count was only 0.14. We
repeated the multivariable Cox proportional hazard models with
leukocyte count included as a covariate, and the results were
essentially unchanged, with only a very slight attenuation of the
risk estimates. Neutrophil gelatinase-associated lipocalin was still a
strong, independent predictor of cardiovascular disease death and
of the combined cardiovascular end point in fully adjusted models
that included leukocyte count. In addition, the association with
all-cause mortality remained significant in models adjusted for age,
sex, and leukocyte count, with borderline significance after adjust-
ing further for other risk factors. Thus, neutrophil gelatinase-
associated lipocalin seems to be an independent predictor of cardio-
